Nuwellis, Inc. to Announce Fourth Quarter 2021 Financial Results on March 1, 2022
Nuwellis, Inc. (NASDAQ: NUWE) will release its fourth quarter 2022 financial results on March 1, 2022, followed by a conference call at 9:00 AM ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Nuwellis, Inc. (NASDAQ: NUWE) will release its fourth quarter 2022 financial results on March 1, 2022, followed by a conference call at 9:00 AM ET. The company focuses on innovative solutions for patients with fluid overload and markets the Aquadex SmartFlow® system for ultrafiltration therapy. Investors can access the live webcast on the company's website or join the conference call via specified phone numbers. Nuwellis is headquartered in Minneapolis, MN, and operates a subsidiary in Ireland.
Positive
- Focus on innovation in fluid overload treatment with Aquadex SmartFlow® system.
- Scheduled conference call for financial results demonstrates transparency to investors.
Negative
- None.
Details
News Market Reaction – NUWE
The recorded move for NUWE in the trading session of this news was -1.67%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) announced today that its fourth quarter 2022 financial results will be released on Tuesday, March 1, 2022. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.
To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 9353528. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com.
About Nuwellis
Nuwellis, Inc. (Nasdaq: NUWE) is a medical device company dedicated to transforming the lives of patients suffering from fluid overload through science, collaboration, and innovation. The Company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow® system for ultrafiltration therapy. Nuwellis is headquartered in Minneapolis, MN, with a wholly-owned subsidiary in Ireland.
Investor Contacts:
George Montague, CFA
Chief Financial Officer, Nuwellis, Inc.
ir@nuwellis.com
Matt Bacso, CFA
Gilmartin Group LLC
Matt.bacso@gilmartinir.com
Media Contact:
Laurel Hood
Health+Commerce
laurel@healthandcommerce.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.